Cancers, Free Full-Text

Por um escritor misterioso

Descrição

Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.
Cancers, Free Full-Text
Clinical Genitourinary Cancer, Journal
Cancers, Free Full-Text
National Comprehensive Cancer Network - Home
Cancers, Free Full-Text
Cancer free hi-res stock photography and images - Alamy
Cancers, Free Full-Text
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers, Breast Cancer Research
Cancers, Free Full-Text
Pancreatic Cancer Action Network – Research, Patient Support, Resources
Cancers, Free Full-Text
Know the signs of cancer to catch it early
Cancers, Free Full-Text
Home Page: Lung Cancer
Cancers, Free Full-Text
Breast - Archives of Pathology & Laboratory Medicine
Cancers, Free Full-Text
Prostate Cancer: Symptoms, Causes & Treatment
Cancers, Free Full-Text
Download or order free information booklets
Cancers, Free Full-Text
I Am Cancer Free! - Cancer Free Gift - Tapestry
Cancers, Free Full-Text
Cancer - Wiley Online Library
Cancers, Free Full-Text
European Journal of Cancer Prevention
Cancers, Free Full-Text
MD Anderson Cancer Center: Cancer Treatment & Cancer Research Hospital
de por adulto (o preço varia de acordo com o tamanho do grupo)